Meal replacement system for Type 2 Diabetes
Study Summary
This trial is testing a meal replacement system to see if it can help people with Type 2 Diabetes go into remission without the use of medications.
- Type 2 Diabetes
- Obesity
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
What is the aggregate amount of individuals taking part in this research?
"Affirmative. According to records accessible via clinicaltrials.gov, this medical trial is continuing its recruitment efforts having been initially posted on August 1st 2022 and last updated on June 28th 2022. As of now, the study requires 50 people from one site."
What criteria must potential participants meet to be qualified for inclusion in this study?
"This research requires 50 participants aged between 25-65 who suffer from type 2 diabetes mellitus, as well as being male or female and having had the condition for no more than five years. Additionally, it is requisite that all subjects take oral agents to manage their medical condition and are able to converse in English."
Are individuals over the age of 55 able to participate in this experiment?
"This current trial is enrolling individuals aged 25 and over, but under 65 years old."
Are there any available slots for participants in this clinical trial?
"Affirmative. According to information publicly available on clinicaltrials.gov, this medical trial is currently accepting applications from participants. The study was initially published on August 1st 2022 and has since been updated as of June 28th 2022; 50 individuals are needed across a single location for enrolment purposes."